? Currently, chimeric chickens are made by injecting blastodermal cells or chicken embryonic stem cells into stage X recipient embryos, but the frequency and the level of chimerism is variable and not predictable. We are developing a universal recipient that contributes minimally, so that the contribuion of donor dervied celld to the resulting chimera is constantly high and predictable. ? ? In phase I of this SBIR project, a lentiviral vector for the universal recipient chicken line and for a GFP control line was generated and evaluated by transducing stage X chicken embryos with a lentiviral vector. The results clearly demonstrated the feasibility of a lentiviral approach for the establishment of the universal recipient transgenic chicken lines. ? ? In phase II of this grant application, we plan to generate the universal recipient chicken lines using the lentiviral approach. The project is unique and innovative because it seeks to establish a reliable and reproducible method of compromising the recipient embryos to consistently yield high-grade chimeras and allow the production of significant amounts of protein per egg in a short period of time. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44GM070158-03
Application #
7105482
Study Section
Special Emphasis Panel (ZRG1-GGG-J (10))
Program Officer
Portnoy, Matthew
Project Start
2004-02-04
Project End
2008-03-31
Budget Start
2006-08-01
Budget End
2008-03-31
Support Year
3
Fiscal Year
2006
Total Cost
$782,541
Indirect Cost
Name
Origen Therapeutics
Department
Type
DUNS #
026167994
City
Emeryville
State
CA
Country
United States
Zip Code
94608